Related Experiment Video
Updated: Aug 31, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
The role of triple therapy in patients with chronic stable angina pectoris
Insights
For chronic stable angina, triple therapy with beta-blockers, calcium channel blockers, and nitrates may benefit select patients. However, vasodilation side effects and patient suitability require careful consideration.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Beta-blockers and calcium-channel blockers are effective monotherapies for chronic stable angina pectoris.
- Some patients remain symptomatic despite monotherapy and benefit from combined treatments.
Purpose of the Study:
- To evaluate the effectiveness and limitations of combined and triple therapy regimens for chronic stable angina.
- To assess the role of calcium channel blockers and nitrates in managing refractory angina symptoms.
Main Methods:
- Review of existing studies on combination therapy (beta-blockers and nitrates, beta-blockers and calcium channel blockers).
- Analysis of evidence regarding triple therapy (beta-blockers, calcium channel blockers, and nitrates).
Main Results:
- Combination therapy with beta-blockers and nitrates or calcium channel blockers offers benefits for symptomatic patients.
- Triple therapy may provide additional benefit for patients refractory to dual therapy, but vasodilation side effects like orthostatic hypotension are a concern.
- Limited long-term data exists for calcium blocker-nitrate combinations.
Conclusions:
- Triple therapy can be valuable for selected chronic stable angina patients unresponsive to dual therapy.
- Caution is advised in patients with reduced left ventricular function or conduction system disease due to potential vasodilation side effects and exclusion from studies.
Abstract:
Despite the proven effectiveness of calcium-channel and beta-blockers as monotherapy in patients with chronic stable angina pectoris, some patients remain symptomatic. Such patients have been shown to benefit from the application of combined treatment with beta-blockers and nitrates or, more recently, beta-blockers plus calcium-channel blockers. There have been few studies evaluating the long-term effectiveness of the combination of calcium blockers and nitrates, but available evidence suggests that symptoms of excessive vasodilation such as orthostatic hypotension may limit the usefulness of this approach. Recently, the additional benefit of adding a calcium blocker to therapy of patients with chronic stable angina who remain symptomatic on beta-blockers and nitrates has been demonstrated. Side effects related to vasodilation were the major limiting feature of this triple therapy. Thus, a triple therapy regimen may be of value in selected patients who do not respond to the combination of beta-blockers and nitrates or beta-blockers plus calcium blockers. However, caution must be exercised in patients with reduced left ventricular function and conduction system disease, since such patients have been excluded from the reported studies.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Angina V: Nursing Management
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care

